12DA.HM
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
5 more panels on 12DA.HM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $113.54B | $95.57B | $88.42B | $102.30B | +18.8% |
| Operating revenue | $113.54B | $95.57B | $88.42B | $102.30B | +18.8% |
| Cost of revenue | $90.83B | $74.32B | $67.36B | $79.61B | +22.2% |
| Gross profit | $22.71B | $21.25B | $21.07B | $22.69B | +6.9% |
| Research & development | $3.14B | $3.06B | $2.80B | $2.78B | +2.6% |
| Selling, general & admin | $11.12B | $11.53B | $12.34B | $14.14B | -3.6% |
| Total operating expense | $14.26B | $14.59B | $15.14B | $16.91B | -2.3% |
| Operating income | $8.45B | $6.66B | $5.93B | $5.77B | +26.9% |
| Net interest income | -$1.28B | -$1.25B | -$1.17B | -$1.18B | -2.2% |
| Pre-tax income | $7.26B | $5.05B | $4.09B | $3.23B | +43.9% |
| Tax provision | $1.33B | $472.00M | $715.00M | $803.00M | +181.1% |
| Net income | $5.94B | $4.59B | $3.39B | $2.44B | +29.3% |
| Net income to common | $5.94B | $4.59B | $3.39B | $2.44B | +29.3% |
| Basic EPS | 8.79 | 6.51 | 4.55 | 3.33 | +35.0% |
| Diluted EPS | 8.68 | 6.38 | 4.55 | 3.24 | +36.1% |
| EBIT | $8.82B | $6.46B | $5.59B | $4.51B | +36.5% |
| EBITDA | $11.85B | $9.59B | $8.89B | $7.66B | +23.7% |
| Basic shares | 675.00M | 705.00M | 706.34M | 734.00M | -4.3% |
| Diluted shares | 684.00M | 720.00M | 706.34M | 753.00M | -5.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $11.53B | $3.63B | $7.37B | $8.61B | +217.3% |
| Cash & short-term investments | $11.53B | $3.63B | $7.37B | $8.61B | +217.3% |
| Accounts receivable | $17.59B | $10.30B | $9.34B | $12.48B | +70.8% |
| Inventory | $10.44B | $6.72B | $3.62B | $4.78B | +55.4% |
| Total current assets | $57.60B | $36.23B | $35.98B | $42.35B | +59.0% |
| Property, plant & equipment | $6.68B | $6.34B | $6.43B | $6.21B | +5.4% |
| Goodwill & intangibles | $24.08B | $24.11B | $25.40B | $26.14B | -0.1% |
| Total assets | $101.29B | $79.75B | $82.13B | $89.61B | +27.0% |
| Total current liabilities | $63.27B | $46.53B | $48.35B | $51.65B | +36.0% |
| Current debt | $7.99B | $5.20B | $6.98B | $6.57B | +53.5% |
| Long-term debt | $23.51B | $19.36B | $19.01B | $23.02B | +21.4% |
| Total debt | $31.50B | $24.57B | $25.99B | $29.59B | +28.2% |
| Total liabilities | $103.76B | $81.13B | $84.26B | $92.64B | +27.9% |
| Retained earnings | $3.33B | -$1.16B | -$4.45B | -$6.73B | +386.6% |
| Shareholder equity | -$2.47B | -$1.48B | -$2.23B | -$3.12B | -66.7% |
| Working capital | -$5.67B | -$10.30B | -$12.37B | -$9.30B | +45.0% |
| Net tangible assets | -$26.55B | -$25.59B | -$27.63B | -$29.27B | -3.8% |
| Shares issued | 843.77M | 834.13M | 822.34M | 798.00M | +1.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $5.94B | $4.58B | $3.37B | $2.42B | +29.7% |
| Depreciation & amortisation | $3.03B | $3.12B | $3.30B | $3.16B | -3.0% |
| Stock-based compensation | $723.00M | $785.00M | $878.00M | $931.00M | -7.9% |
| Change in working capital | $843.00M | -$4.21B | $605.00M | -$3.19B | +120.0% |
| Operating cash flow | $11.19B | $4.52B | $8.68B | $3.56B | +147.4% |
| Capital expenditure | -$2.63B | -$2.65B | -$2.76B | -$3.00B | +0.7% |
| Investing cash flow | -$2.06B | -$2.21B | -$2.78B | -$3.02B | +7.2% |
| Share buybacks | -$6.40B | -$3.17B | -$2.45B | -$3.28B | -102.3% |
| Dividends paid | -$1.46B | -$1.27B | -$1.07B | -$964.00M | -14.4% |
| Financing cash flow | -$1.46B | -$5.82B | -$7.09B | -$1.63B | +74.8% |
| Free cash flow | $8.55B | $1.87B | $5.92B | $562.00M | +357.6% |
| End cash position | $11.71B | $3.82B | $7.51B | $8.89B | +206.5% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $46.97B | $43.84B | $33.38B | $27.00B | $29.78B | +7.1% |
| Operating revenue | $46.97B | $43.84B | $33.38B | $27.00B | $29.78B | +7.1% |
| Cost of revenue | $37.14B | $36.06B | $26.65B | $21.41B | $24.33B | +3.0% |
| Gross profit | $9.83B | $7.78B | $6.73B | $5.59B | $5.45B | +26.3% |
| Research & development | $1.11B | $983.00M | $797.00M | $752.00M | $785.00M | +12.8% |
| Selling, general & admin | $3.25B | $3.04B | $2.79B | $2.67B | $2.76B | +7.0% |
| Total operating expense | $4.36B | $4.02B | $3.58B | $3.42B | $3.55B | +8.4% |
| Operating income | $5.47B | $3.76B | $3.15B | $2.17B | $1.90B | +45.5% |
| Net interest income | -$254.00M | -$322.00M | -$315.00M | -$314.00M | -$333.00M | +21.1% |
| Pre-tax income | $5.13B | $3.95B | $2.80B | $1.94B | $1.44B | +30.0% |
| Tax provision | $998.00M | $510.00M | $540.00M | $393.00M | $276.00M | +95.7% |
| Net income | $4.13B | $3.44B | $2.26B | $1.55B | $1.16B | +20.2% |
| Net income to common | $4.13B | $3.44B | $2.26B | $1.55B | $1.16B | +20.2% |
| Basic EPS | 6.41 | 5.30 | 3.47 | 2.31 | 1.72 | +20.9% |
| Diluted EPS | 6.34 | 5.24 | 3.37 | 2.28 | 1.70 | +21.0% |
| EBIT | $5.47B | $4.35B | $3.21B | $2.34B | $1.90B | +25.8% |
| EBITDA | $6.23B | $5.11B | $3.98B | $3.09B | $2.66B | +21.9% |
| Basic shares | 645.00M | 649.00M | 651.77M | 671.00M | 678.00M | -0.6% |
| Diluted shares | 652.00M | 656.00M | 670.33M | 680.00M | 686.00M | -0.6% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.57B | $11.58B | $11.53B | $9.57B | $8.14B | -0.1% |
| Cash & short-term investments | $11.57B | $11.58B | $11.53B | $9.57B | $8.14B | -0.1% |
| Accounts receivable | $22.92B | $25.85B | $17.59B | $11.72B | $15.02B | -11.4% |
| Inventory | $21.29B | $15.05B | $10.44B | $6.95B | $7.21B | +41.4% |
| Total current assets | $80.55B | $70.61B | $57.60B | $43.10B | $45.51B | +14.1% |
| Property, plant & equipment | $7.42B | $6.95B | $6.68B | $6.54B | $6.46B | +6.8% |
| Goodwill & intangibles | $23.80B | $23.94B | $24.08B | $23.99B | $24.08B | -0.6% |
| Total assets | $127.39B | $114.91B | $101.29B | $87.48B | $89.18B | +10.9% |
| Total current liabilities | $83.70B | $74.60B | $63.27B | $50.52B | $54.86B | +12.2% |
| Current debt | $8.48B | $7.55B | $7.99B | $7.39B | $7.15B | +12.3% |
| Long-term debt | $25.98B | $23.61B | $23.51B | $23.85B | $21.54B | +10.1% |
| Total debt | $34.47B | $31.16B | $31.50B | $31.24B | $28.69B | +10.6% |
| Total liabilities | $128.82B | $116.32B | $103.76B | $90.10B | $91.94B | +10.7% |
| Retained earnings | $10.06B | $6.34B | $3.33B | $1.42B | $231.00M | +58.7% |
| Shareholder equity | -$1.43B | -$1.40B | -$2.47B | -$2.62B | -$2.77B | -1.6% |
| Working capital | -$3.16B | -$3.99B | -$5.67B | -$7.41B | -$9.35B | +20.9% |
| Net tangible assets | -$25.22B | -$25.35B | -$26.55B | -$26.61B | -$26.85B | +0.5% |
| Shares issued | 640.10M | 851.53M | 843.77M | 843.76M | 842.71M | -24.8% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $4.13B | $3.44B | $2.26B | $1.55B | $1.16B | +20.2% |
| Depreciation & amortisation | $754.00M | $758.00M | $773.00M | $756.00M | $762.00M | -0.5% |
| Stock-based compensation | $184.00M | $189.00M | $189.00M | $165.00M | $179.00M | -2.6% |
| Change in working capital | -$2.76B | $38.00M | $1.22B | -$1.46B | $94.00M | -7,355.3% |
| Operating cash flow | $2.23B | $4.08B | $4.67B | $1.17B | $2.54B | -45.5% |
| Capital expenditure | -$1.24B | -$963.00M | -$721.00M | -$669.00M | -$675.00M | -28.7% |
| Investing cash flow | -$1.34B | -$1.07B | -$695.00M | -$617.00M | -$655.00M | -25.3% |
| Share buybacks | -$3.81B | -$2.17B | -$1.86B | -$1.27B | -$945.00M | -76.2% |
| Dividends paid | -$405.00M | -$464.00M | -$346.00M | -$351.00M | -$366.00M | +12.7% |
| Financing cash flow | -$882.00M | -$2.95B | -$2.09B | $857.00M | -$1.47B | +70.1% |
| Free cash flow | $986.00M | $3.12B | $3.95B | $503.00M | $1.87B | -68.4% |
| End cash position | $11.74B | $11.75B | $11.71B | $9.73B | $8.29B | -0.1% |
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Sep 29, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Sep 21, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Sep 10, 26 | RBC Capital | INITIATED | — | Outperform |
| Sep 9, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Sep 2, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Sep 2, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Sep 2, 26 | Melius Research | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Sep 2, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Sep 2, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.